Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity

Details for Australian Patent Application No. 2007304847 (hide)

Owner Inimex Pharmaceuticals, Inc.

Inventors Donini, Oreola; Rozek, Annett; Lentz, Shannon Wayne

Agent Peter Maxwell & Associates

Pub. Number AU-A-2007304847

PCT Pub. Number WO2008/040111

Priority PCT/ CA2006/001650 04.10.06 CA

Filing date 3 April 2007

Wipo publication date 10 April 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 38/06 (2006.01) Medicinal preparations containing peptides - Tripeptides

A61K 38/07 (2006.01) Medicinal preparations containing peptides - Tetrapeptides

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/00 (2006.01) Antiparasitic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/083 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/09 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/10 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/11 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12Q 1/00 (2006.01) Measuring or testing processes involving enzymes or micro-organisms

C12Q 1/37 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving peptidase or proteinase

G01N 33/573 (1970.01) Investigating or analysing materials by specific methods not covered by groups - for enzymes or isoenzymes

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/040111 Priority application(s): WO2008/040111

10 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

26 July 2012 Section 223 Application Allowed

  Inimex Pharmaceuticals, Inc. The time in which to request examination has been extended to 03 Jun 2012 . Address for service in Australia - Peter Maxwell & Associates Level 6 60 Pitt Street Sydney NSW 2000 2009

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007304849-Apparatus for controlling the placement of seeds within a furrow

2007304839-Furanone compounds and lactam analogues thereof